FDA clears Medtronics stent for use in iliac arteries

Justine Varieur Cadet | | Health Imaging | Screening
Medtronic has received FDA approval for the Complete SE vascular stent system to be used for the treatment of peripheral arterial disease in the iliac arteries.

The Complete SE vascular stent system features a dual-deployment delivery system with a triaxial design, according to the Minneapolis-based company. The new delivery system is made up of an inner shaft, a retractable sheath and a stabilizing sheath.

Robert Molnar, MD, of Michigan Vascular Research Center in Flint, and William Gray, MD, director of endovascular intervention at New York-Presbyterian Hospital/Columbia University Medical Center in New York City, led the study (as co-principal investigators) that contributed to this approval.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.